≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of breast, HER-positive (controls excluding all cancers)

PheWeb

C3_BREAST_ERPLUS_EXALLC

No definition available.

Endpoint definition

↥
FinnGen phenotype data

individuals

diagram downward connector
diagram bullet

Apply sex-specific rule

Sex only females

diagram downward connector
diagram bullet

Check conditions

RX_ERPLUS

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Cause of death: ICD-10 C50
Cause of death: ICD-9 174
Cause of death: ICD-8 174
Cancer registry: Topography ICD-O-3 C50
Cancer registry: Morphology ICD-O-3 ANY
Cancer registry: Behaviour codes [23]

2 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

9698

diagram downward connector
C3_BREAST_ERPLUS_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE
Control conditions not RX_ERPLUS

Extra metadata

Level in the ICD hierarchy 2
First used in FinnGen datafreeze DF9

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 9698 9698 -
Unadjusted prevalence (%) 2.57 4.60 -
Mean age at first event (years) 59.34 59.34 -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.94 [1.48, 2.55] 1.8e-6 735
15 years 0.01 1.37 [1.08, 1.73] 9.0e-3 382
5 years 0.00 2.38 [1.92, 2.94] 1.7e-15 230
1 year 0.00 0.56 [0.29, 1.06] 7.4e-2 10

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_BREAST_ERPLUS_EXALLC – Malignant neoplasm of breast, HER-positive (controls excluding all cancers)
GWS hits: 39

Survival analyses between endpoints

↥

Plot

before Malignant neoplasm of breast, HER-positive (controls excluding all cancers)
after Malignant neoplasm of breast, HER-positive (controls excluding all cancers)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Malignant neoplasm of breast, HER-positive (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.